164 related articles for article (PubMed ID: 27047987)
21. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
Castera L; Winnock M; Pambrun E; Paradis V; Perez P; Loko MA; Asselineau J; Dabis F; Degos F; Salmon D
HIV Med; 2014 Jan; 15(1):30-9. PubMed ID: 24007567
[TBL] [Abstract][Full Text] [Related]
22. Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection.
Lieveld FI; Smit C; Richter C; van Erpecum KJ; Spanier BWM; Gisolf EH; Vrolijk JM; Siersema PD; Hoepelman AIM; Reiss P; Arends JE
Liver Int; 2019 Mar; 39(3):470-483. PubMed ID: 30411848
[TBL] [Abstract][Full Text] [Related]
23. Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV.
Peters MG; Bacchetti P; Boylan R; French AL; Tien PC; Plankey MW; Glesby MJ; Augenbraun M; Golub ET; Karim R; Parkes J; Rosenberg W
AIDS; 2016 Mar; 30(5):723-9. PubMed ID: 26595542
[TBL] [Abstract][Full Text] [Related]
24. Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.
Swanson S; Ma Y; Scherzer R; Huhn G; French AL; Plankey MW; Grunfeld C; Rosenberg WM; Peters MG; Tien PC
J Infect Dis; 2016 Apr; 213(7):1079-86. PubMed ID: 26621911
[TBL] [Abstract][Full Text] [Related]
25. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.
Jaquet A; Wandeler G; Nouaman M; Ekouevi DK; Tine J; Patassi A; Coffie PA; Tanon A; Seydi M; Attia A; Dabis F
J Int AIDS Soc; 2017 Feb; 19(1):21424. PubMed ID: 28362065
[TBL] [Abstract][Full Text] [Related]
26. Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.
Macías J; Mancebo M; Márquez M; Merino D; Téllez F; Rivero A; von Wichmann MA; López-Cortés LF; Merchante N; Santos J; Raffo M; Pérez-Pérez M; Camacho Á; Iribarren JA; Pineda JA
Hepatology; 2015 May; 61(5):1503-11. PubMed ID: 25545020
[TBL] [Abstract][Full Text] [Related]
27. Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individuals.
Rohrbach J; Stickel F; Schmid P; Thormann W; Kovari H; Scherrer A; Günthard HF; Vuichard D; Cavassini M; Ambrosioni J; Bernasconi E; Furrer H; Rauch A;
Antivir Ther; 2014; 19(2):149-59. PubMed ID: 24036684
[TBL] [Abstract][Full Text] [Related]
28. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
[TBL] [Abstract][Full Text] [Related]
29. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
[TBL] [Abstract][Full Text] [Related]
30. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V
J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993
[TBL] [Abstract][Full Text] [Related]
31. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).
Nguyen Truong T; Laureillard D; Lacombe K; Duong Thi H; Pham Thi Hanh P; Truong Thi Xuan L; Chu Thi N; Luong Que A; Vu Hai V; Nagot N; Tuaillon E; Dominguez S; Lemoine M
PLoS One; 2016; 11(5):e0153744. PubMed ID: 27148964
[TBL] [Abstract][Full Text] [Related]
32. Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy.
Fuster D; Planas R; Muga R; Ballesteros AL; Santos J; Tor J; Sirera G; Guardiola H; Salas A; Cabré E; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Tural C
AIDS Res Hum Retroviruses; 2004 Dec; 20(12):1293-7. PubMed ID: 15650421
[TBL] [Abstract][Full Text] [Related]
33. HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality.
Klein MB; Rollet KC; Saeed S; Cox J; Potter M; Cohen J; Conway B; Cooper C; Côté P; Gill J; Haase D; Haider S; Hull M; Moodie E; Montaner J; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall M; Walmsley S;
HIV Med; 2013 Jan; 14(1):10-20. PubMed ID: 22639840
[TBL] [Abstract][Full Text] [Related]
34. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
Abruzzi A; Fried B; Alikhan SB
Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
[TBL] [Abstract][Full Text] [Related]
35. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
Bräu N
Semin Liver Dis; 2005 Feb; 25(1):33-51. PubMed ID: 15731996
[TBL] [Abstract][Full Text] [Related]
36. The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.
Núñez-Torres R; Macías J; Mancebo M; Frías M; Dolci G; Téllez F; Merino D; Merchante N; Gómez-Mateos J; Guaraldi G; Rivero-Juárez A; Pineda JA; Real LM;
PLoS One; 2016; 11(12):e0168265. PubMed ID: 27973562
[TBL] [Abstract][Full Text] [Related]
37. Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.
Sangal RB; Taylor LE; Gillani F; Poppas A; Klinger JR; Ventetuolo CE
Ann Am Thorac Soc; 2014 Dec; 11(10):1553-9. PubMed ID: 25375659
[TBL] [Abstract][Full Text] [Related]
38. Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.
Macías J; Berenguer J; Japón MA; Girón-González JA; Rivero A; López-Cortés LF; Moreno A; Márquez M; Iribarren JA; Ortega E; Miralles P; Merchante N; Pineda JA
Hepatology; 2012 Oct; 56(4):1261-70. PubMed ID: 22508322
[TBL] [Abstract][Full Text] [Related]
39. Fibrosis Progression in Paired Liver Biopsies from HIV/HCV-Coinfected Patients without Prior Treatment of Hepatitis C.
Leite AG; Duarte MI; Mendes-Correa MC
J Int Assoc Provid AIDS Care; 2015; 14(5):463-8. PubMed ID: 26056147
[TBL] [Abstract][Full Text] [Related]
40. Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis.
Casado JL; Mena A; Bañón S; Castro A; Quereda C; Moreno A; Pedreira J; Moreno S
HIV Med; 2016 Jan; 17(1):62-7. PubMed ID: 26122981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
